Академический Документы
Профессиональный Документы
Культура Документы
In accordance with 154.4 of the Standing Order, Senior Party hereby provides below a
current listing of its exhibits in Interference No. 106,048.
EXHIBIT
DESCRIPTION
NO.
1001
U.S. Patent Application No. 13/842,859, filed on March 15, 2013, to Jennifer
Doudna et al. (the 859 Application)
1002
1003
U.S. Provisional Application No. 61/652,086, filed on May 25, 2012, to Martin
Jinek et al. (the 086 Provisional or the First Provisional)
1004
1005
1006
1007
U.S. Patent No. 8,697,359, issued on April 15, 2014, to Feng Zhang (the 359
Patent)
1008
U.S. Patent No. 8,771,945, issued on July 8, 2014, to Feng Zhang (the 945
Patent)
1009
U.S. Patent No. 8,945,839, issued on February 3, 2015, to Feng Zhang (the 839
Patent)
DESCRIPTION
NO.
1010
U.S. Patent No. 8,889,356, issued on November 18, 2014, to Feng Zhang (the
356 Patent)
1011
U.S. Patent No. 8,932,814, issued on January 13, 2015, to Le Cong and Feng
Zhang (the 814 Patent)
1012
U.S. Patent No. 8,795,965, issued on August 5, 2014, to Feng Zhang (the 965
Patent)
1013
U.S. Patent No. 8,871,445, issued on October 28, 2014, to Le Cong and Feng
Zhang (the 445 Patent)
1014
U.S. Patent No. 8,865,406, issued on October 21, 2014, to Feng Zhang and Fei
Ran (the 406 Patent)
1015
U.S. Patent No. 8,895,308, issued on November 25, 2014, to Feng Zhang and Fei
Ran (the 308 Patent)
1016
U.S. Patent No. 8,906,616, issued on December 9, 2014, to Feng Zhang et al.
(the 616 Patent)
1017
U.S. Patent No. 8,993,233, issued on March 31, 2015 to Feng Zhang et al. (the
233 Patent)
1018
U.S. Patent No. 8,999,641, issued on April 7, 2015 to Feng Zhang et al. (the
641 Patent)
1019
U.S. Patent Application No. 14/704,551, filed on May 5, 2015 to Feng Zhang et
al. (the 551 Application)
DESCRIPTION
NO.
1020
1021
1022
1023
1024
1025
1026
1027
1028
Mercier et al., A Transcription Factor Cascade Involving Fep1 and the CCAATBinding Factor Php4 Regulates Gene Expression In Response To Iron Deficiency
in the Fission Yeast Schizosaccharomyces pombe, 5(11) EUKARYOTIC CELL 18661881 (2006) (Mercier)
1029
Dai et al., The Transcription Factors GATA4 and dHAND Physically Interact to
Synergistically Activate Cardiac Gene Expression Through a p300-dependent
Mechanism, 277(27) J. BIOL. CHEM. 24390-24398 (2002) (Dai)
1030
1031
DESCRIPTION
NO.
1032
Deltcheva et al., CRISPR RNA maturation by trans-encoded small RNA and host
factor RNase III, 471 NATURE 602-607 (2011) with Supplementary Materials
(Deltcheva)
1033
1034
Wang et al., Targeted gene addition to a predetermined site in the human genome
using a ZFN-based nicking enzyme, 22(7) GENOME RES. 1316-1326 (2012)
(Wang)
1035
1036
1037
1038
DESCRIPTION
NO.
1039
Boden et al., Efficient Gene Transfer of HIV-1-Specific Short Hairpin RNA into
Human Lymphocytic Cells Using Recombinant Adeno-associated Virus Vectors,
9(3) MOL. THER. 396-402 (2004) (Boden)
1040
1041
NUCL. ACIDS CHEM. BIOL. Chpt. 4 (B.M. Blackburn et al., 3rd ed. 2006)
(Blackburn)
1042
1043
Mahfouz et al., Targeted Transcriptional Repression Using a Chimeric TALESRDX Repressor Protein, 78 PLANT MOL. BIOL. 311-321 (2012) (Mahfouz)
1044
1045
1046
1047
1048
DESCRIPTION
NO.
1049
1050
Lee et al., Targeted Chromosomal Deletions in Human Cells Using Zinc Finger
Nucleases, 20(1) GENOME RES. 81-89 (2010) (Lee)
1051
1052
1053
1054
1055
1056
1057
1058
1059
Cho et al., Targeted Genome Engineering in Human Cells With the Cas9 RNAGuided Endonuclease, 31(3) NAT. BIOTECHNOL. 230-232 (2013) with
Supplemental Information (Cho)
1060
1061-1124
DESCRIPTION
NO.
1125
1126
Nam et al., Cas5d Protein Processes Pre-crRNA and Assembles into a Cascadelike Interference Complex in Subtype I-C/Dvulg CRISPR-Cas System, 20
STRUCTURE 1574-1584 (2012) (Nam)
1127-1151
1152
1153
1154
1155
1156
1157
McIntyre and Fanning, Design and cloning strategies for constructing shRNA
expression vectors, 6 BMC BIOTECHNOL. 1-8 (2006) (McIntyre)
1158
DESCRIPTION
NO.
1159
1160
1161
1162
1163
1164
1165
1166
1167
Le Rhun et al., Small RNAs in streptococci, 9:4 RNA BIOLOGY 414-426, DOI:
10.4161/rna.20104 (April 2012)
1168
DESCRIPTION
NO.
1169
1170
1171
1172
Swarts et al., CRISPR interference directs strand specific spacer acquisition, 7(4)
PLOS ONE e35888 (2012)
1173
1174
1175
1176
1177
1178
DESCRIPTION
NO.
1179
1180
1181
1182
1183
1184
1185
1186
1187
1188
1189
10
DESCRIPTION
NO.
1190
1191
1192
1193
Alberts B., et al., MOLECULAR BIOLOGY OF THE CELL, 38, 59 (3rd ed. 1994)
1194
1195
1196
1197
Ausubel (Ed), Short Protocols in Molecular Biology, pages 9-3 to 9-4 (1999)
1198
11
DESCRIPTION
NO.
1199
1200
Behr et al., Efficient gene transfer into mammalian primary endocrine cells with
lipopolyamine-coated DNA, 86 PNAS 6982-6986 (1989)
1201
1202
1203
1204
1205
1206
12
DESCRIPTION
NO.
1207
1208
1209
Bolotin et al., Complete sequence and comparative genome analysis of the dairy
bacterium Streptococcus thermophilus, 22(12) NAT. BIOTECHNOL. 1554-1558
(2004)
1210
Bouard et al., Viral Vectors: from virology to transgene expression, 157 BRITISH
JOURNAL OF PHARMACOLOGY 153-165 (2009)
1211
Brouns et al., Small CRISPR RNAs guide antiviral defense in prokaryotes, 321
SCIENCE 960-964 (2008)
1212
Campeau et al., A versatile viral system for expression and depletion of proteins
in mammalian cells, 4(8) PLOS ONE e6529 (2009)
1213
1214
Carroll, Genome Engineering With Zinc-Finger Nucleases, 188 GENETICS 773782 (2011)
1215
Carte et al., Cas6 is an endoribonuclease that generates guide RNAs for invader
defense in prokaryotes, 22(24) GENES DEV. 3489-3496 (2008)
13
DESCRIPTION
NO.
1216
Cermak et al., Efficient design and assembly of custom TALEN and other TAL
effector-based constructs for DNA targeting, 39(12) NUCLEIC ACIDS RES. e82
(2011)
1217
Chiu et al., Engineered GFP as a vital reporter in plants, 6(3) CURR. BIO. 325330 (1996)
1218
Choulika, et al., Transfer of single gene-containing long terminal repeats into the
genome of mammalian cells by a retroviral vector carrying the cre gene and the
loxP site, 70(3) J. VIROL. 1792-1798 (1996)
1219
1220
Cost et al., BAK and BAX deletion using zinc-finger nucleases yields apoptosisresistant CHO cells, 105(2) BIOTECHNOL. BIOENG. 330-340 (2010)
1221
1222
Cradick et al., ZFN-Site Searches Genomes for Zinc Finger Nuclease Target Sites
and Off-Target Sites, 12 BMC BIOINFORMATICS 1-10 (2011)
1223
Crasto and Feng, A LINKER: a program to generate linker sequences for fusion
proteins, 13(5) PROTEIN ENGIN. 309-312 (2000)
1224
14
DESCRIPTION
NO.
1225
Davis and Cui, Zinc Finger Nucleases for Genome Editing, 30(13) GEN. ENG. &
BIOTECH NEWS 1-3 (2010)
1226
1227
1228
Drag and Salvesen, DeSUMOylating enzymes--SENPs. 60(11) IUBMB Life 734742 (2008)
1229
Dykxhoorn et al., Killing the Messenger: Short RNAs That Silence Gene
Expression, 4 NATURE REV. 457-467 (2003)
1230
1231
European Patent No. 2341149 A1, published July 6, 2011 (Danisco A/S)
1232
1233
1234
15
DESCRIPTION
NO.
1235
1236
1237
1238
1239
1240
1241
1242
1243
1244
1245
16
DESCRIPTION
NO.
1246
1247
1248
Gorman et al., High efficiency gene transfer into mammalian cells, B307 PHIL.
TRANS. R. SEC. LAND. 343-346 (1984)
1249
1250
1251
Gritti, Gene therapy for lysosomal storage disorders, 11(9) EXPERT OPIN BIOL
THER. 1153-1167 (2011)
1252
1253
1254
17
DESCRIPTION
NO.
1255
1256
Hale et al., Essential features and rational design of CRISPR RNAs that function
with the Cas RAMP module complex to cleave RNAs, 45(3) MOL CELL 292-302
(2012) (Hale 2012)
1257
1258
1259
Hanna et al., Treatment of Sickle Cell Anemia Mouse Model with iPS Cells
Generated from Autologous Skin, 318 SCIENCE 1920-1923 (2007)
1260
1261
1262
18
DESCRIPTION
NO.
1263
1264
Hockemeyer et al., Highly efficient gene targeting of expressed and silent genes
in human ESCs and iPSCs using zinc-finger nucleases, 27(9) NAT BIOTECHNOL
851-857 (2009)
1265
Hockemeyer et al., Genetic engineering of human ES and iPS cells using TALE
nucleases, 29(8) NATURE BIOTECHNOLOGY 731-734 (2011)
1266
Hofling et al., Human CD34+ hematopoietic progenitor cell-directed lentiviralmediated gene therapy in a xenotransplantation model of lysosomal storage
disease, 9(6) MOL. THER. 856-865 (2004)
1267
1268
1269
1270
Ishino et al., Nucleotide sequence of the iap gene, responsible for alkaline
phosphates isozyme conversion in Escherichia coli, and identification of the gene
product, 169(12) J. BACTERIOL. 5429-5433 (1987)
19
DESCRIPTION
NO.
1271
Jansen et al., Identification of genes that are associated with DNA repeats in
prokaryotes, 43(6) MOLECULAR MICROBIOLOGY 1565-1575 (2002)
1272
1273
145-154 (2005)
1274
1275
1276
Lambowitz and Zimmerly, Group II introns: mobile ribozymes that invade DNA,
3(8) COLD SPRING HARB PERSPECT BIOL. a003616 (2011)
1277
1278
1279
Lemay et al., Folding of the Adenine Bioswitch, 13 CHEMISTRY & BIOLOGY 857868 (2006)
1280
Lewin et al. (eds.), Nuclear localization sequences target proteins to the nucleus
in CELLS 224(5.12) (2007)
20
DESCRIPTION
NO.
1281
Lewis et al., The c-myc and PyMT Oncogenes Induce Different Tumor Types in a
Somatic Mouse Model for Pancreatic Cancer, 17 GENES DEV. 3127-3138 (2003)
1282
Li et al., Modularly assembled designer TAL effector nucleases for targeted gene
knockout and gene replacement in eukaryotes, 39(14) NUCL. ACIDS RES. 63156325 (2011)
1283
1284
1285
Lombardo et al., Gene editing in human stem cells using zinc finger nucleases
and integrase-defective lentiviral vector delivery, 25(11) NAT. BIOTECHNOL.
1298-1306 (2007)
1286
1287
Makarova et al., Unification of Cas protein families and a simple scenario for the
origin and evolution of CRISPR-Cas systems, 6 BIOL DIRECT. 38 (2011)
1288
21
DESCRIPTION
NO.
1289
1290
1291
Marraffini and Sontheimer, Self vs. non-self discrimination during CRISPR RNAdirected immunity, 463(7280) NATURE 568-571 (2010)
1292
1293
1294
1295
Miller et al., A TALE nuclease architecture for efficient genome editing, 29(2)
NATURE BIOTECHNOL. 143-150 (2011)
1296
Minton, How Can Biochemical Reactions Within Cells Differ From Those in Test
Tubes?, 119 JOURNAL OF CELL SCIENCE 2863-2869 (2006)
1297
22
DESCRIPTION
NO.
1298
Mojica et al., Short motif sequences determine the targets of the prokaryotic
CRISPR defence system, 155(3) MICROBIOLOGY 733-740 (2009) with
Supplementary Data
1299
1300
Mojica et al., Long stretches of short tandem repeats are present in the largest
replicons of the Archaea Haloferax mediterranei and Haloferax volcanii and
could be involved in replicon partitioning, 17(1) MOL MICROBIOL 85-93 (1995)
1301
1302
1303
1304
Mussolino et al., A novel TALE nuclease scaffold enables high genome editing
activity in combination with low toxicity, 39(21) NUCL. ACIDS RES. 9283-9293
(2011)
1305
23
DESCRIPTION
NO.
1306
1307
Neumann et al., Gene transfer into mouse lyoma cells by electroporation in high
electric fields, 1(7) EMBO JOURNAL 841-845 (1982)
1308
1309
Nomura et al., Low-density Lipoprotein Receptor Gene Therapy Using HelperDependent Adenovirus Produces Long-term Protection Against Atherosclerosis
in a Mouse Model of Familial Hypercholesterolemia, 11 GENE THERAPY 15401548 (2004)
1310
1311
1312
24
DESCRIPTION
NO.
1313
1314
1315
1316
1317
PCR Applications Manual 3rd ed., 1-340 (Roche Diagnostics GmbH 2006)
1318
1319
1320
Porteus and Carroll, Gene targeting using zinc finger nucleases, 23(8) NAT.
BIOTECHNOL. 967-973 (2005)
1321
25
DESCRIPTION
NO.
1322
1323
Povirk et al., Role of Braca 1 in Nonhomologous DNA End Joining, U.S. Army
Medical Research and Material Command, Award No. DAMD 17-03-01-0620
(September 2004)
1324
Radulovich et al., Modified gateway system for double shRNA expression and
Cre/lox based gene expression, 11 BMC BIOTECHNOL. 24 (2011)
1325
Ramsubir et al., In vivo delivery of human acid ceramidase via cord blood
transplantation and direct injection of lentivirus as novel treatment approaches
for Farber disease, 95(3) MOL GENET METAB 133-141 (2008)
1326
Rand et al., Argonaute2 cleaves the anti-guide strand of siRNA during RISC
activation, 123(4) CELL 621-629 (2005)
1327
1328
1329
26
DESCRIPTION
NO.
1330
Saito et al., Identification of four acidic amino acids that constitute the catalytic
center of the RuvC Holliday junction resolvase, 92 PROC. NATL. ACAD. SCI. USA
7470-7474 (1995)
1331
1332
1333
1334
1335
27
DESCRIPTION
NO.
1336
1337
1338
Shieh et al., Nuclear Targeting of the Maize R Protein Requires Two Nuclear
Localization Sequences 101 PLANT PHYSIOL 353-361 (1993)
1339
1340
Singer and Verma, Applications of Lentiviral Vectors for shRNA Delivery and
Transgenesis, 8(6) CURR. GENE THER. 483-88 (2008)
1341
1342
1343
28
DESCRIPTION
NO.
1344
1345
SUEPO Working Paper, A Quality Strategy for the EPO; available at:
http://www.suepo.org/public/docs/2002/quality.pdf (2002).
1346
Sun et al., Optimized TAL effector nucleases (TALENs) for use in treatment of
sickle cell disease, 8(4) MOLECULAR BIOSYSTEMS 1255-1263 (2012)
1347
1348
1349
1350
1351
1352
Tinland et al., The T-DNA-linked VirD2 protein contains two distinct functional
nuclear localization signals, 89 PROC. NATL. ACAD. SCI. USA 7442-7446 (1992)
1353
29
DESCRIPTION
NO.
1354
Tolia and Joshua-Tor, Slicer and the argonautes, 3(1) NAT. CHEM. BIOL. 36-43
(2007)
1355
Tsien, The Green Fluorescent Protein, 67 ANNU. REV. BIOCHEM. 509-544 (1998)
1356
Urnov et al., Genome editing with engineered zinc finger nucleases, 11 NAT REV.
GENET. 636-646 (2010)
1357
Urnov et al., Highly efficient endogenous human gene correction using designed
zinc-finger nucleases, 435(7042) NATURE 646-651 (2005)
1358
van Til et al., Lentiviral gene therapy of murine hematopoietic stem cells
ameliorates the Pompe disease phenotype, 115(26) BLOOD 5329-5337 (2010)
1359
1360
Wang et al., Genetic correction of -thalassemia patient-specific iPS cells and its
use in improving hemoglobin production in irradiated SCID mice, 22(4) CELL
RES. 637-648 (2012)
1361
1362
Welch et al., Designing Genes for Successful Protein Expression, 498 METHODS
IN ENZYMOLOGY
1363
43-66 (2011)
30
DESCRIPTION
NO.
1364
1365
1366
1367
1368
Zhang et al., cSSMD: assessing collective activity for addressing off-target effects
in genome-scale RNA interference screens, 27(20) BIOINFORMATICS 2775-2781
(2011)
1369
Zhou et al., Mouse model for the lysosomal disorder galactosialidosis and
correction of the phenotype with overexpressing erythroid precursor cells, 9(21)
GENES AND DEV. 2623-2634 (1995)
1370
Rouillon et al., Structure of the CRISPR Interference Complex CSM Reveals Key
Similarities with Cascade, 52(1) MOL. CELL. 124134 (2013) (Rouillon)
1371
31
DESCRIPTION
NO.
1372
DiCarlo et al., Genome engineering in Saccharomyces cerevisiae using CRISPRCas systems, 41(7) NUCL. ACIDS RES. 4336-4343 (2013) (DiCarlo)
1373
1374
1375
1-6 (2013)
Xu, The next generation biotechnology for Apple improvement and beyond: The
CRISPR/Cas9 Story, 21(4) NEW YORK FRUIT QUARTERLY 19-22 (2013)
1376
1377
1378
1379
1380
1381
1382
1383
32
DESCRIPTION
NO.
1384
U.S. Patent No. 5,766,900, issued on June 16, 1998 to Shillito et al.
1385
U.S. Patent No. 5,767,367, issued on June 16, 1998 to Dudits et al.
1386
1387
1388
1389
1390
1391
1392
1393
1394
1395
33
DESCRIPTION
NO.
1396
1397
1398
1399
1400
1401
1402
1403
1404
1405
34
DESCRIPTION
NO.
1406
1407
1408
1409
1410
1411
1412
1413
1414
1415
1416
35
DESCRIPTION
NO.
1417
1418
1419
1420
1421
1422
1423
1424
1425
1426
36
DESCRIPTION
NO.
1427
1428
1429
1430
1431
1432
1433
1434
1435
1436
37
DESCRIPTION
NO.
1437
1438
1439
1440
1441
1442
1443
1444
1445
1446
38
DESCRIPTION
NO.
1447
1448
1449
1450
1451
1452
1453
1454
1455
1456
1457
1458
1459
1460
39
DESCRIPTION
NO.
1461
1462
1463
1464
1465
1466
1467
1468
1469
1470
1471
1472
1473
1474
1475
40
DESCRIPTION
NO.
1476
1477
1478
1479
1480
1481
1482
1483
1484
Aziz et al., Transposases are the most abundant, most ubiquitous genes in nature,
38(13) NUCLEIC ACIDS RES. 4207-4217 (2010)
1485
41
DESCRIPTION
NO.
1486
1487
Aravind et al., Survey and Summary: Holliday junction resolvases and related
nucleases: identification of new families, phyletic distribution and evolutionary
trajectories, 28(18) NUCLEIC ACIDS RES. 3417-3432 (2000)
1488
1489
1490
Davis and Stokoe, Zinc Finger Nucleases as tools to understand and treat human
diseases, 8:42 BMC MEDICINE (2010)
1491
Titz et al., Transcriptional activators in yeast, 34(3) NUCLEIC ACIDS RES. 955-67
(2006)
1492
1493
Hewitt, The MHC class I antigen presentation pathway: strategies for viral
immune evasion, 110(2) IMMUNOLOGY 163-69 (2003)
1494
42
DESCRIPTION
NO.
1495
1496
Day and Davidson, The fluorescent protein palette: tools for cellular imaging,
38(1) CHEM. SOC. REV. 2887-2921 (2009)
1497
Jansa et al., The transcript release factor PTRF augments ribosomal gene
transcription by facilitating reinitiation of RNA polymerase I, 29(2) NUCL. ACIDS
RES. 423-32 (2001)
1498
Yang and Seto, HATs and HDACs: from structure, function and regulation to
novel strategies for therapy and prevention, 26 ONCOGENE 5310-5318 (2007)
1499
1500
1501
McConnell Smith et al., Generation of a nicking enzyme that stimulates sitespecific gene conversion from the I-Anil LAGLIDADG homing endonuclease,
106(13) PNAS 5099-5104 (2009)
1502
M. Kido et al., Escherichia coli RecA protein modified with a nuclear localization
signal binds to chromosomes in living mammalian cells, 198 EXPERIMENTAL
CELL RESEARCH 107-114 (1992)
1503
1504
1505
43
DESCRIPTION
NO.
1506
Jans et al., Nuclear targeting signal recognition: a key control point in nuclear
transport?, 22 BIOESSAYS 532-544 (2000)
1507
1508
Kim et al., Highly efficient RNA-guided genome editing in human cells via
delivery of purified Cas9 ribonucleoproteins, 24 GENOME RES. 1012-1019 (2014)
with Supplemental Information
1509
1510
Sung et al., Highly efficient gene knockout in mice and zebrafish with RNAguided endonucleases, 24 GENOME RES. 125-131 (2014) with Supplemental
Material
1511
1512
1513
Office Action dated January 13, 2014 in U.S. Patent Application No. 14/054,414
1514
Claims filed on December 12, 2013 in U.S. Patent Application No. 14/105,017
1515
Office Action dated November 13, 2014 in U.S. Patent Application No.
14/105,017
1516
Claims filed on February 18, 2014 in U.S. Patent Application No. 14/183,429
44
DESCRIPTION
NO.
1517
Office Action dated April 9, 2014 in U.S. Patent Application No. 14/183,429
1518
1519
Final Office Action dated November 18, 2014 in U.S. Patent Application No.
14/256,912
1520
1521
Final Office Action dated November 18, 2014 in U.S. Patent Application No.
14/226,274
1522
Preliminary Amendment filed on July 27, 2015 in U.S. Patent Application No.
14/704,551
1523
Office Action dated August 14, 2015 in U.S. Patent Application No. 14/704,551
1524
Claims filed on February 18, 2014 in U.S. Patent Application No. 14/183,471
1525
Office Action dated July 1, 2014 in U.S. Patent Application No. 14/183,471
1526
Claims filed on April 22, 2014 in U.S. Patent Application No. 14/258,458
1527
Office Action dated July 14, 2014 in U.S. Patent Application No. 14/258,458
1528
45
DESCRIPTION
NO.
1529
Suggestion of Interference, filed April 13, 2015, in U.S. Patent Application No.
13/842,859 without Appendices
1530
1531
1532
1533
Corrected Filing Receipt, dated December 11, 2015 in U.S. Patent Application
No. 13/842,859
1534
1535
1536
Boehm et al., One of three nuclear localization signals of maize Activator (Ac)
transposase overlaps the DNA-binding domain, 7(3) THE PLANT JOURNAL 441451 (1995)
1537
1538
46
DESCRIPTION
NO.
1539
Alberts B., et al., MOLECULAR BIOLOGY OF THE CELL, Chpt. 12, pp. 671-676 (4th
ed. 2002)
1540
1541
Dang and Lee, Identification of the Human c-myc Protein Nuclear Translocation
Signal, 8(10) MOLECULAR AND CELLULAR BIOLOGY 4048-4054 (1988)
1542
1543
Greenspan et al., Two Nuclear Location Signals in the Influenza Virus NS1
Nonstructural Protein, 62(8) JOURNAL OF VIROLOGY 3020-3026 (1988)
1544
Alberts B., et al., MOLECULAR BIOLOGY OF THE CELL, Chpt. 4, pp. 191-234 (4th
ed. 2002)
1545
U.S. Provisional Application No. 61/717,324, filed October 23, 2012 to Seung
Woo Kim et al. (Toolgen Provisional)
1546
Yarris, Programmable DNA Scissors Found for Bacterial Immune System (June
28, 2012) downloaded from http://newscenter.lbl.gov/2012/06/28/programmabledna-scissors/ on June 13, 2016
1547
1548
Vence, Heroes of CRISPR Disputed (January 19, 2016), downloaded from THE
SCIENTIST at http://www.the-scientist.com/?articles.view/articleNo/45119/title/Heroes-of-CRISPR--Disputed/ on July 29, 2016
47
DESCRIPTION
NO.
1549
1550
Johnson, A social media war just erupted over the biotech innovation of the
century in The Washington Post (January 20, 2016) available at
https://www.washingtonpost.com/news/wonk/wp/2016/01/20/is-a-history-ofbiotechs-hottest-breakthrough-propaganda/
1551
1552
Internet Outrage is Shaping the Battle Over CRISPR, by Sarah Zhang (Jan. 20,
2016) downloaded from http://www.wired.com/2016/01/crispr-twitter-fight/ on
July 29, 2016
1553
Comments on The Heroes of CRISPR, 164 CELL 18-28 (2016) downloaded from
http://www.cell.com/cell/comments/S0092-8674(15)01705-5 on July 31, 2016
1554
1555
1556
1557
[REDACTED] Email from Jin-Soo Kim to Jennifer Doudna, dated July 16, 2012
1558
1559
Email from George Church to Jennifer Doudna, dated November 14, 2012
48
DESCRIPTION
NO.
1560
1561
1562
1563
1564
1565
Wang and Carmichael, Effects of Length and Location on the Cellular Response
to Double-Stranded RNA, 68(3) MICROBIOLOGY AND MOLECULAR BIOLOGY
REVIEWS 432-452 (2004)
1566
Sdbeck and Scherer, Two Independent Nuclear Localization Signals Are Present
in the DNA-Binding High-Mobility Group Domains of SRY and SOX9, 272(44) J.
BIOL. CHEM. 27848-27852 (1997)
1567
1568
49
DESCRIPTION
NO.
1569
1570
1571
1572
Esvelt et al., Orthogonal Cas9 proteins for RNA-guided gene regulation and
editing, 10(11) NATURE METHODS 1116-1123 (2013)
1573
1574
1575
1576
Ill and Chiou, Gene Therapy Progress and Prospects: Recent progress in
transgene and RNAi expression cassettes, 12 GENE THERAPY 795-802 (2005)
1577
Gibson and Shillitoe, Ribozymes Their Functions and Strategies for Their Use,
7 MOL. BIOTECHNOL. 125-137 (1997)
50
DESCRIPTION
NO.
1578
1579
Fuerst et al., Use of a Hybrid Vaccinia Virus-T7 RNA Polymerase System for
Expression of Target Genes, 7(7) MOL. AND CELL. BIOL. 2538-2544 (1987)
1580
Dulon and Ryan, The bacterial Neo gene confers neomycin resistance to
mammalian cochlear hair cells, 10 NEUROREPORT 1189-1193 (1999)
1581
1582
1583
1584
1585
Lieber et al., High level gene expression in mammalian cells by a nuclear T7phage RNA polymerase, 17(21) NUCL. ACIDS RES. 8485-8493 (1989)
1586
1587
1588
51
DESCRIPTION
NO.
1589
Luo et al., Multiple Nuclear Localization Sequences Allow Modulation of 5Lipoxygenase Nuclear Import, 5 TRAFFIC 847-854 (2004)
1590
1591
1592
Los et al., HalotagTM Technology: Cell Imaging and Protein Analysis, 14 CELL
NOTES 10-14 (2006)
1593
1594
1595
Nagy et al., Creation and Use of a Cre Recombinase Transgenic Database, Gene
Knockout Protocols, Chpt. 19, pp. 365-378 (Ralf Khn, Wolfgang Worst eds. 2nd
ed. 2009)
1596
1597
Chen et al., A Facile System for encoding Unnatural Amino Acids in Mammalian
Cells, 48(22) ANGEW CHEM. INT. ED. ENGL. 4052-4055 (2009)
1598
52
DESCRIPTION
NO.
1599
1600
1601
Office Action dated December 5, 2013 in U.S. Patent Application No. 14/054,414
with Notice of References Cited
1602
1603
1604
1605
1606
1607
Mali et al., CAS9 transcriptional activators for target specificity screening and
paired nickases for cooperative genome engineering, 31(9) NAT. BIOTECHNOL.
833-838 (2013)
53
DESCRIPTION
NO.
1608
1609
Ding et al., Enhanced efficiency of human pluripotent stem cell genome editing
through replacing TALENs with CRISPRs, 12(4) CELL STEM CELL 393-394
(2013)
1610
1611
1612
1613
1614
1615
1616
1617
Email from Shuailiang Lin to Feng Zhang and Neville Sanjana dated November
5, 2011 (Exhibit 4 to Neville Sanjana Declaration, dated July 23, 2015)
54
DESCRIPTION
NO.
1618
1619
1620
1621
1622
1623
1624
1625
1626
55
DESCRIPTION
NO.
1627
1628
U.S. Provisional Application No. 61/717,324, filed October 23, 2012 to Seung
Woo Kim et al. (Toolgen Provisional)
1629
1630
September 7, 2016
1631
1632
Press Release, FNIH Awards Lurie Prize to Jennifer Doudna (February 24, 2014),
available at http://www.fnih.org/news/press-releases/lurie-prize-in-thebiomedical-sciences-to-jennifer-doudna
1633
Press Release, The Gruber Foundation, Yale University, 2015 Gruber Genetics
(June 16, 2015) available at http://gruber.yale.edu/genetics/press/2015-grubergenetics-press-release
56
DESCRIPTION
NO.
1634
1635
1636
1637
1638
Deposition Transcript of Ronald Breaker, Ph.D., September 13, 2016, with errata
1639
Deposition Transcript of Paul Simons, Ph.D., September 15, 2016, with errata
57
Respectfully submitted,
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
58
/Todd R. Walters/
Todd R. Walters, Esq.
Registration No. 34,040
BUCHANAN INGERSOLL & ROONEY PC
1737 King Street, Suite 500
Alexandria, VA 22314
Telephone (703) 836-6620
Facsimile (703) 836-2021
todd.walters@bipc.com
Counsel for UC and Vienna